Clinical Trial Update: Adjuvant Dendritic Cell Immunotherapy for Pediatric Patients With High-grade Glioma or Diffuse Intrinsic Pontine Glioma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating adjuvant dendritic cell immunotherapy in pediatric high-grade glioma and diffuse intrinsic pontine glioma; the study is currently act…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Intrinsic Pontine Glioma
• High-grade Glioma

Drugs mentioned

• Adjuvant Dendritic Cell Immunotherapy (dendritic cell immunotherapy)

Snippet

Sponsor: University Hospital, Antwerp | Conditions: High Grade Glioma, Diffuse Intrinsic Pontine Glioma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING